Know Labs Sells Control to Greg Kidd’s Firm in $15M + 1,000 BTC Deal
Know Labs, Inc., a health-tech company focused on non-invasive monitoring, has announced a groundbreaking deal to sell a controlling interest to Goldeneye 1995 LLC, an affiliate of fintech investor Greg Kidd. The $128 million deal includes 1,000 Bitcoin and between $12 to $15 million in cash and is expected to close in Q3 2025.
The proceeds will help Know Labs repay debts, repurchase preferred stock, and fund operations. Shares will be sold at $0.335—below the current trading price of $0.51—with the total number of shares based on the value of BTC and cash divided by the share price.
Greg Kidd, former Chief Risk Officer at Ripple and early investor in Coinbase and Twitter, will become CEO and Chairman. His Bitcoin yield strategy will now go public through Know Labs, with BTC becoming the primary asset—82% of the company’s estimated market cap.
Founder Ron Erickson becomes Vice Chairman and head of a new R&D division. His salary drops to $375,000. Peter Conley will exit after the deal closes.
About 37% of shareholders already support the transaction. Cohen & Company Capital Markets is advising, with legal help from Lowenstein Sandler LLP and Sichenzia Ross Ference Carmel LLP.
You might also like : XRP Whale Moves $59M to Coinbase Ahead of Ripple-SEC Deadline
